Abstract
Background/Aim: Ovarian cancer remains one of the most commonly encountered malignancies affecting women worldwide, that is unfortunately commonly diagnosed in advanced stages of the disease. In these stages, the tumoral process usually involves the surrounding viscera throughout contiguity or induces the apparition of distant metastases via peritoneal, lymphatic or hematogenous spread, multiple resections being needed in order to achieve a good control of the disease. Patients and Methods: In the present study, we present a case series of 12 patients in whom various surgical procedures on the rectosigmoidian loop were performed in order to achieve debulking surgery to no residual disease. Results: Digestive tract resections consisted of rectosigmoidian resection with left colostomy in three cases, low rectosigmoidian resections with anastomosis in eight cases and a stripping procedure of the peritoneal layer in one case. Conclusion: Due to the close proximity of the digestive and gynecological tract, advanced-stage ovarian tumors frequently involve the rectosigmoidian loop, imposing association of digestive tract surgical procedures.
Ovarian cancer is a common malignancy encountered in women worldwide, presenting an increasing incidence in the last decades. Among European women it is estimated that the incidence of ovarian cancer reached 4% of all malignancies, being in the meantime the sixth cause of cancer related death (1, 2). This fact is mainly related to the high capacity of spread of the malignant process via multiple pathways, leading to the apparition of disseminated lesions at the time of diagnosis. In these cases, despite advances in chemotherapy, the five-year survival rate remains low, the most significant prognostic factor remaining the stage of disease at diagnosis and the completion of cytoreductive surgery (3-10). Intuited for the first time by Meigs (4) in 1934 and demonstrated four decades later by Griffiths (5), the principles of debulking surgery became the standard of care whenever disseminated lesions are encountered. When it comes to the presence of disseminated lesions involving the lower digestive tract, multiple surgical procedures might be taken in consideration in order to maximize the debulking effort as well as the functional outcome and, in the meantime to minimize the risk of postoperative complications (11-14).
Patients and Methods
We present a case series of 12 patients diagnosed with advanced stage ovarian cancer with rectosigmoidian involvement submitted to surgery between 2014 and 2016. In all cases at least one digestive tract resection was performed. At the end of each surgical procedure, two drainage tubes were placed in the pelvic area in all cases while the decompression naso-gastric tube was left in place until the intestinal transit was re-established.
Results
The mean age at diagnosis was 56.5 years (range=33-78 years). Preoperative status was assessed based on ASA score, eight patients being classified as having ASA score I-II while the other four patients were classified as having ASA score III. The main associated comorbidities included cachexia in two cases, morbid obesity in three cases, diabetes mellitus in two cases and cardiovascular disease in one case. Both patients presenting cachexia were diagnosed with low preoperative levels of albumin, prealbumin and total proteins. In all cases the surgical procedure consisted of total hysterectomy with bilateral adnexectomy, pelvic and para-aortic lymph node dissection, omentectomy, parietal and pelvic peritonectomy and at least one procedure of digestive surgery. Digestive tract resections consisted of rectosigmoidian resection with left colostomy in three cases (Figures 1 and 2) (the two cachectic patients with low preoperative levels of albumin, prealbumin and total proteins and one case with morbid obesity, atherosclerosis and diabetes mellitus), low rectosigmoidian resections with anastomosis in eight cases (Figures 3, 4 and 5) while in the last case the rectosigmoidian loop was entirely preserved, only the peritoneal surface being resected through a stripping procedure (Figures 6, 7 and 8). However, in this last case, a digestive resection concerning an ileal loop was required. Other associated resections included diaphragmatic resections in two cases, splenectomy in two cases, atypical liver resection in one case, partial cystectomy in one case and subtotal gastrectomy in one case. The mean operative time was 210 min (range 120-320 min). The mean blood loss was 350 ml (range 200-750 ml) while intraoperative blood transfusion was needed in two cases. Postoperatively one patient requiring a low anterior rectal resection developed a minimal anastomotic leak which was successfully managed in a conservative manner. It was the case of a 48-year-old patient who was diagnosed with a large pelvic, abscessed tumor with ovarian origin invading the rectosigmoidian loop and an ileal loop who was submitted to a total hysterectomy with bilateral adnexectomy, pelvic and para-aortic lymph node dissection, low rectosigmoidian resection with colo-rectal anastomosis, segmental enterectomy and entero-enteral anastomosis; in the meantime the patient was also submitted to an atypical hepatectomy for an isolated liver metastasis. In this case the postoperative complication was rather related to the presence of the local signs of sepsis due to the abscessed tumor at the time of resection then to the nutritional status of the patient.
The decision of performing only peritoneal stripping of the Douglas pouch was taken in a patient diagnosed with stage IIIC ovarian cancer with disseminated peritoneal lesions at this level, but with no evidence of deep invasion of the rectosigmoidian layer. The same surgical procedure was also performed at the level of the anterior surface of the rectosigmoid colon and on the peritoneal surface of the urinary bladder where disseminated small nodules were also encountered. In this case, although the rectosigmidian loop was entirely preserved, the resection of an ileal loop was imposed by the presence of the disseminated tumoral lesions on the mesenteric surface.
Discussion
Once the principle of debulking surgery to no residual disease became the golden standard in advanced stage and relapsed ovarian cancer, the situation in which multiple visceral resections were performed in order to achieve this golden standard became a common one. In the last decade improvement of the surgical technique of both pelvic and upper abdominal surgical procedures including hepato-bilio-pancreatic procedures encouraged the oncosurgical teams to include these types of procedures in the armamentarium of debulking surgery with good short-term and long-term results, maximizing in this way the cytoreductive effort (14-20).
When it comes to the necessity of bowel resection as part of the debulking surgery for advanced-stage ovarian cancer, the type of surgical procedure which is performed should take into consideration multiple factors such as the depth of invasion of the peritoneal nodules, the patient's nutritional and biological status as well as the extent of the lesions. In most cases the decision of what procedure is the most suitable for each patient is taken intraoperatively, after a close inspection of the local situation and after the integration of these aspects in the general status of each case. Whenever the surgical team decides to perform a low rectosigmoidian resection with anastomosis, the surgeon should take into consideration the fact that in this context the risk of anastomotic dehiscence remains one of the most frequent and serious complications, ranging between 0.8 and 6.8% (21, 22). In the meantime, the factors contributing to a higher risk of anastomotic leaks consist of a higher length of operative time, a higher need of blood transfusion and a shorter length of the distal anastomotic partner (2). Whenever one of these situations are encountered, performing a diverting ileostomy or even a Hartmann procedure might be performed in order to minimize the risk of a life-threatening complication such as an anastomotic leak.
In order to determine the impact of rectosigmoidian resection as part of debulking surgery for advanced-stage ovarian cancer, Kalogera et al. conducted a study on 42 patients submitted to multiple bowel resections for advanced stage ovarian cancer who experienced postoperative anastomotic leaks, these results being compared to a similar group of 84 controls – patients with similar preoperative characteristics submitted to debulking surgery which included bowel resections but who did not experience any anastomotic leak. The author demonstrated that the addition of another large bowel resection to rectosigmoidian resection associated with a significantly higher risk of anastomotic leak (p=0.025) while the decision of performing a protective ileostomy significantly decreased the risk of anastomotic leak (p=0.024). In the same study, other factors such as BMI value, ASA score, diabetes mellitus or smoking did not significantly influence the apparition of anastomotic leaks (23).
When it comes to the decision of performing a Douglas peritonectomy or rectosigmoidian resection with anastomosis, one of the most important factors which will influence the therapeutic strategy is related to the depth of invasion of the peritoneal nodules. Although peritonectomy of the Douglas cul de sac with rectosigmoidian preservation is usually procedure of choice, the local involvement might impose performing a more radical surgical procedure such as rectosigmoidian resection. However, if complete cytoreduction is achieved it seems that similar rates of survival are expected, independently of the procedure of choice. One of the largest studies conducted on this theme comes from Gallotta et al. and was published in 2011 in the European Journal of Surgical Oncology. In this study, the authors included 187 patients with advanced stage ovarian cancer who were submitted to pelvic peritonectomy of Douglas pouch (116 cases) and to rectosigmoidian resections (in 71 cases). The authors reported similar rates of disease free and overall survival between the two groups, demonstrating the efficacy of the two procedures as long as the desideratum of complete debulking surgery is achieved (24). The same study also demonstrated that the rate of pelvic recurrence was significantly higher among patients submitted to peritonectomy when compared to those submitted to per primam rectosigmoidian resection. However, this fact did not significantly influence survival due to the fact that whenever pelvic recurrence was suspected the patient was submitted to secondary cytoreductive surgery (24). These data are only partially in agrrement with those reported by Alletti et al. who demonstrated that performing a peritoneal stripping of the Douglas pouch is associated with higher rates of recurrence and significantly lower rates of a five-year overall survival when compared to rectosigmoidian resection. Alletti explained the poorer outcome of cases submitted to pelvic peritonectomy when compared to those submitted to rectosigmoidian resection through the fact that the exact extent of the disease in the depth of the rectal wall can be easily underestimated; in this situation, performing a peritonectomy might leave in place a high amount of tumor cells in the inner layers of the rectosigmoidian loop, predisposing both to a higher recurrence rate and a lower rate of long-term survival (14).
Conclusion
Due to the close proximity of the gynecological and the digestive tract, rectosigmoidian involvement can be frequently encountered in cases presenting advanced-stage ovarian malignancies. The presence of extended pelvic lesions should not preclude obtaining a complete macroscopic resection of the tumoral burden and to increase the rate of long-term survival. However, the type of surgical procedure should be carefully chosen, after a close inspection of the local degree of invasion of the lesions and after integrating this information with the general and biological status of the patient.
Footnotes
This article is freely accessible online.
- Received June 4, 2017.
- Revision received July 2, 2017.
- Accepted July 4, 2017.
- Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved